Please assess the completion status of the following clinical trial:

Trial Title: A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Community-dwelling children and adolescents 2 to 17 years of age.~* Written Informed Consent or Assent.~* Acute respiratory illness documented at study visit or at home with fever (oral temperature ≥ 100.0° Fahrenheit at study visit, or history of fever reported by parents, or use of antipyretic prior to study visit)~* Symptom onset less than 5 days prior to study visit.~* Subject and/or subject's legal representative is able to understand and comply with the requirements of the protocol as judged by the investigator.~Exclusion Criteria:~* Treatment with an antiviral drug for influenza (oseltamivir or Tamiflu®, zanamivir or Relenza®) during the 14 days before enrollment~* Any condition that, in the opinion of the investigator, would interfere with interpretation of subject safety or study results~* Concurrent enrollment in another clinical study~Patient already enrolled during this influenza season~* Employees of the clinical study site or any other individuals involved with the conduct of the study, or immediate family members of such individuals.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 17 Years
- Healthy Volunteers: t

Study Arms:
- Q/LAIV (Type: None): FluMist Quadrivalent
- Inactivated Influenza Vaccine (Type: None): Inactivated Influenza Vaccine

Based on this trial design, predict the completion outcome and termination type (if applicable).